Homocysteine‐lowering interventions for preventing cardiovascular events
Información
- DOI:
- https://doi.org/10.1002/14651858.CD006612.pub3Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 31 enero 2013see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Corazón
- Copyright:
-
- Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Arturo Marti‐Carvajal took the lead on writing up the Cochrane review.
Ivan Solà identified trials, extracted data, edited the 'Summary of findings' table and drafted the Cochrane review.
Dimitris Lathyris extracted and checked the data and reviewed the Cochrane review.
Despoina‐Elvira Karakitsiou checked the data, drafted the Cochrane review.
Daniel Simancas‐Racines checked the data and the 'Risk of bias' table.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Iberoamerican Cochrane Centre, Spain.
Academic
-
Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador.
Academic
-
Cochrane Heart Group, UK.
Academic
Declarations of interest
Ivan Solà, Dimitrios Lathyris, Despoina‐Elvira Karakitsiou and Daniel Simancas‐Racines: none known.
In 2004 Arturo Martí‐Carvajal was employed by Eli Lilly to run a four‐hour workshop on 'how to critically appraise clinical trials on osteoporosis and how to teach this'. This activity was not related to his work with The Cochrane Collaboration or any Cochrane review.
In 2007 Arturo Martí‐Carvajal was employed by Merck to run a four‐hour workshop 'how to critically appraise clinical trials and how to teach this'. This activity was not related to his work with The Cochrane Collaboration or any Cochrane review.
Acknowledgements
We express our gratitude to Cochrane Heart Group and peer referees for the suggestions to enhance the quality of this review. In addition, we acknowledge Dr Temis Maria Felix for giving us permission to publish the Figure 1 from Brustolin 2010, to Carmen Verônica Abdala from BIREME/OPS/OMS for her help to develop the strategy of the search in LILACS. In addition, we want express our deep gratitude to Georgia Salanti for teaching us how to conduct the first version of this Cochrane review.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 Aug 17 | Homocysteine‐lowering interventions for preventing cardiovascular events | Review | Arturo J Martí-Carvajal, Ivan Solà, Dimitrios Lathyris, Mark Dayer | |
| 2015 Jan 15 | Homocysteine‐lowering interventions for preventing cardiovascular events | Review | Arturo J Martí‐Carvajal, Ivan Solà, Dimitrios Lathyris | |
| 2013 Jan 31 | Homocysteine‐lowering interventions for preventing cardiovascular events | Review | Arturo J Martí‐Carvajal, Ivan Solà, Dimitrios Lathyris, Despoina‐Elvira Karakitsiou, Daniel Simancas‐Racines | |
| 2009 Oct 07 | Homocysteine lowering interventions for preventing cardiovascular events | Review | Arturo J Martí‐Carvajal, Ivan Solà, Dimitrios Lathyris, Georgia Salanti | |
| 2009 Jul 08 | Homocysteine lowering interventions for preventing cardiovascular events | Protocol | Arturo J Martí‐Carvajal, Georgia Salanti, Ricardo Hidalgo, Agustín Ciapponi | |
Differences between protocol and review
This update includes a trial sequential analysis.
In this previous version (Marti‐Carvajal 2009), we searched into Allied and Complementary Medicine ‐ AMED (accessed through Ovid), and the Cochrane Stroke Group Specialised Register. For this update, we did not search either database.
